Dublin-based Mainstay’s back pain trials cap a memorable year

Dublin-based medical devices company Mainstay Medical has taken the first steps towards testing what it hopes with be a revolutionary treatment for chronic back pain.

More than 40 people have had the company’s implantable device tested as part of the ReActiv8-A clinical trial.

The trial, along with an expansion of its workforce, saw operating costs climb $2.7m (€2.53m) to $11.1m in the year, however.